You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

pralsetinib

Showing 1 - 5 of 5
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Medullary Thyroid Cancer Trial in Cordoba, Sevilla (Pralsetinib, Cabozantinib, Vandetanib)

Not yet recruiting
  • Medullary Thyroid Cancer
  • Pralsetinib
  • +2 more
  • Cordoba, Spain
  • +1 more
Jan 11, 2023

NSCLC Trial in Worldwide (Alectinib, Entrectinib, Pralsetinib)

Recruiting
  • Non-Small Cell Lung Cancer
  • San José, Costa Rica
  • +3 more
Aug 4, 2022

NSCLC Trial in United States (Alectinib, Entrectinib, Vemurafenib)

Recruiting
  • Non-small Cell Lung Cancer
  • Duarte, California
  • +24 more
Feb 2, 2023

Advanced Unresectable or Metastatic Solid Malignancy Trial in United States (Entrectinib, Inavolisib, Alectinib)

Recruiting
  • Advanced Unresectable or Metastatic Solid Malignancy
  • Birmingham, Alabama
  • +50 more
Aug 10, 2022

Solid Tumors Trial in Worldwide (Entrectinib, Alectinib, Atezolizumab)

Recruiting
  • Solid Tumors
  • Daphne, Alabama
  • +156 more
Jan 13, 2023